Adoptive Immunotherapy for Cancer or Viruses (original) (raw)
Abstract
Adoptive immunotherapy, or the infusion of lymphocytes, is a promising approach for the treatment of cancer and certain chronic viral infections. The application of the principles of synthetic biology to enhance T cell function has resulted in substantial increases in clinical efficacy. The primary challenge to the field is to identify tumor-specific targets to avoid off-tumor, on-target toxicity. Given recent advances in efficacy in numerous pilot trials, the next steps in clinical development will require multicenter trials to establish adoptive immunotherapy as a mainstream technology.
Article metrics loading...
/content/journals/10.1146/annurev-immunol-032713-120136
2014-03-21
2024-11-14
Full text loading...
/deliver/fulltext/immunol/32/1/annurev-immunol-032713-120136.html?itemId=/content/journals/10.1146/annurev-immunol-032713-120136&mimeType=html&fmt=ahah
- Article Type: Review Article
Most Read This Month
Article
content/journals/immunol
Journal
5
3
false
en